No single SSRI is universally “the best” for anxiety, but escitalopram (Lexapro) and sertraline (Zoloft) consistently rank as the top first-line choices across clinical evidence and prescribing practice. Escitalopram shows the strongest efficacy signal for generalized anxiety, while sertraline has the broadest FDA approval across multiple anxiety disorders. The right choice for you depends on your specific type of anxiety, your body’s response, and the side effects you’re most willing to tolerate.
How SSRIs Compare in Clinical Trials
A large network meta-analysis comparing first-line medications for generalized anxiety disorder found that escitalopram produced the greatest reduction in anxiety scores among the SSRIs, lowering Hamilton Anxiety Scale scores by an average of 3.2 points more than placebo. Other medications like duloxetine and venlafaxine (which are SNRIs, not SSRIs) performed similarly, but among SSRIs specifically, escitalopram came out on top.
Interestingly, fluoxetine (Prozac) did not separate from placebo in that same analysis for generalized anxiety, which is one reason it’s not typically a first pick for GAD despite being one of the most widely prescribed antidepressants overall. Fluoxetine does, however, have FDA approval for panic disorder, where it performs better.
Meta-analyses comparing escitalopram to other SSRIs and SNRIs for anxiety with co-occurring depression have found similar response and remission rates across the board. The differences between SSRIs are real but modest, which is why individual factors often tip the scale more than raw efficacy data.
FDA Approvals by Anxiety Type
Not every SSRI is approved for every anxiety disorder, and these distinctions matter when matching medication to diagnosis.
- Generalized anxiety disorder (GAD): escitalopram and paroxetine
- Panic disorder: fluoxetine, sertraline, and paroxetine
- Social anxiety disorder: sertraline and paroxetine
- OCD: fluoxetine, fluvoxamine, sertraline, and paroxetine all carry FDA indications
Sertraline stands out for its versatility. It’s the only SSRI with FDA approval for both social anxiety and panic disorder, and it’s also approved for OCD. If you have overlapping anxiety conditions or your diagnosis isn’t entirely clear, sertraline’s broad coverage makes it a practical starting point. In a 20-week trial for social anxiety, 53% of patients on sertraline showed meaningful improvement compared to 29% on placebo, with notable gains in social functioning and daily activities.
Side Effects That Shape the Decision
Side effects are often the deciding factor, because an SSRI that works perfectly but causes intolerable problems won’t get taken consistently. Across all SSRIs, the most commonly reported side effects include sexual dysfunction (affecting roughly 56% of patients in survey data), drowsiness (53%), and weight gain (49%). But the rates vary meaningfully between individual drugs.
Paroxetine carries the heaviest side effect burden in practice. Studies report sexual dysfunction in nearly all patients taking it, and it’s associated with more weight gain and sedation than other SSRIs. It also has a shorter half-life, which makes it harder to stop. A systematic review in The Lancet Psychiatry identified paroxetine as one of the medications most associated with severe discontinuation symptoms, including dizziness, irritability, nausea, and electric shock-like sensations when doses are missed or tapered too quickly.
Escitalopram tends to be better tolerated. It was linked to discontinuation symptoms in that same review, but the severity was lower than paroxetine’s. Its side effect profile is generally milder, which is one reason prescribers favor it for a first trial. Sertraline falls in a similar tolerability range, though it’s more likely to cause gastrointestinal symptoms like nausea and diarrhea early on.
Fluoxetine has the longest half-life of any SSRI, which makes it the easiest to stop without withdrawal effects. If you’re concerned about discontinuation or tend to occasionally miss doses, that’s a practical advantage worth considering.
How Prescribers Choose Between Them
Clinicians weigh several patient-specific factors when selecting an SSRI. Your particular symptom pattern matters: if anxiety is keeping you awake at night, a mildly sedating option like paroxetine might serve double duty, while if fatigue and low motivation are part of your picture, a more activating choice like sertraline or fluoxetine could be a better fit.
Other medications you take play a role too. Fluoxetine and paroxetine are strong inhibitors of certain liver enzymes, meaning they can raise blood levels of other drugs you might be on. Escitalopram and sertraline have fewer drug interactions, which makes them simpler to combine with other treatments.
Family history can be surprisingly useful. If a parent or sibling responded well to a particular SSRI, there’s a reasonable chance your biology will respond similarly. Pregnancy planning also narrows the options, as some SSRIs have more safety data in pregnancy than others. Sertraline is generally considered one of the better-studied choices for pregnant or breastfeeding patients.
What to Expect When Starting
SSRIs for anxiety are typically started at low doses and increased gradually. Starting doses are deliberately conservative because anxiety symptoms can temporarily worsen in the first week or two before improving. For reference, common starting doses for anxiety are: escitalopram 5 mg, sertraline 25 mg, paroxetine 10 mg, and fluoxetine 10 mg. Maximum therapeutic doses range from 20 mg for escitalopram up to 200 mg for sertraline.
Most people notice some initial improvement within one to four weeks, but it takes up to 12 weeks to feel the full effect. This timeline is important because many people give up on a medication at week three or four, thinking it’s not working, when they simply haven’t reached adequate levels yet. If you’ve been on a full dose for eight to twelve weeks with no meaningful change, that’s a reasonable point to discuss switching.
The Bottom Line on Choosing
If you’re looking for a single answer: escitalopram for generalized anxiety, sertraline for social anxiety or panic disorder. Both are well tolerated, widely prescribed, and have strong evidence behind them. Paroxetine is effective but comes with more side effects and a harder discontinuation process. Fluoxetine is a solid option for panic disorder and OCD, with the added benefit of being easy to taper off.
In practice, finding the right SSRI often involves some trial and adjustment. About half of patients respond well to the first medication tried. For the other half, switching to a different SSRI or adjusting the dose usually gets them to a good result. The differences between SSRIs are small enough that the “best” one is ultimately the one that reduces your anxiety without side effects that undermine your quality of life.